» Articles » PMID: 25259518

IGF-IR Mediated Mammary Tumorigenesis is Enhanced During Pubertal Development

Overview
Journal PLoS One
Date 2014 Sep 27
PMID 25259518
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Although breast cancer typically develops in women over the age of 40, it remains unclear when breast cancer initiating events occur or whether the mammary gland is particularly susceptible to oncogenic transformation at a particular developmental stage. Using MTB-IGFIR transgenic mice that overexpress type I insulin-like growth factor receptor (IGF-IR) in a doxycycline-inducible manner, mammary tumorigenesis was initiated at different developmental stages. Tumor multiplicity was significantly increased while tumor latency was significantly decreased when the IGF-IR transgene was expressed during pubertal development compared to post-pubertal transgene expression. Moreover, metastatic spread of mammary tumors to the lungs was approximately twice as likely when IGF-IR was overexpressed in pubertal mice compared to post-pubertal mice. In addition, engraftment of pubertal MTB-IGFIR mammary tissue into cleared mammary fat pads of pubertal hosts produced tumors more frequently and faster than engraftment into adult hosts. These experiments show that the mammary microenvironment created during puberty renders mammary epithelial cells particularly susceptible to transformation.

Citing Articles

Adolescent- and adult-initiated alcohol exposure in mice differentially promotes tumorigenesis and metastasis of breast cancer.

Xu M, Li H, Chen D, Wu H, Wen W, Xu H Alcohol Clin Exp Res (Hoboken). 2022; 47(2):251-262.

PMID: 36462938 PMC: 10906809. DOI: 10.1111/acer.14986.


Transgenic overexpression of the miR-200b/200a/429 cluster inhibits mammary tumor initiation.

Watson K, Yi R, Moorehead R Transl Oncol. 2021; 14(12):101228.

PMID: 34562686 PMC: 8473771. DOI: 10.1016/j.tranon.2021.101228.


Female breast cancer mortality in relation to puberty on Staten Island, New York.

Levine A, Gerstle D AIMS Public Health. 2020; 7(2):344-353.

PMID: 32617361 PMC: 7327401. DOI: 10.3934/publichealth.2020029.


Rodent Models Assessing Mammary Tumor Prevention by Soy or Soy Isoflavones.

Moorehead R Genes (Basel). 2019; 10(8).

PMID: 31357528 PMC: 6722900. DOI: 10.3390/genes10080566.

References
1.
Russo J, Russo I . Breast development, hormones and cancer. Adv Exp Med Biol. 2008; 630:52-6. DOI: 10.1007/978-0-387-78818-0_4. View

2.
Hassiotou F, Geddes D . Anatomy of the human mammary gland: Current status of knowledge. Clin Anat. 2012; 26(1):29-48. DOI: 10.1002/ca.22165. View

3.
Sivaraman L, Stephens L, Markaverich B, Clark J, Krnacik S, Conneely O . Hormone-induced refractoriness to mammary carcinogenesis in Wistar-Furth rats. Carcinogenesis. 1998; 19(9):1573-81. DOI: 10.1093/carcin/19.9.1573. View

4.
Macon M, Fenton S . Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia. 2013; 18(1):43-61. PMC: 3682794. DOI: 10.1007/s10911-013-9275-7. View

5.
Fenton S . Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology. 2006; 147(6 Suppl):S18-24. DOI: 10.1210/en.2005-1131. View